Abstract LB508: The development of HK013, a bispecific antibody
https://aacrjournals.org/cancerres/article/82/12_Supplement/LB508/699991/Abstract-LB508-The-development-of-HK013-a
WEBJun 15, 2022 · Here, we report the development of a bispecific antibody, HK013, targeting both MSLN and CD137 for the treatment of solid tumors. The bispecific antibody HK013 …
DA: 12 PA: 82 MOZ Rank: 33